Addus HomeCare Corp. (ADUS)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-05
$126.81-0.88%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-05
QuarterlyIQ Insights · ADUS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -2.8% |
| Our one-year growth estimate | diamond | 6.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 9.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 18 industry peers · Company calendar date is not available
ADUS — CEO transition
Dated 2026-08-13
President and COO — Heather Dixon: The President and COO departed the company, representing a loss of a senior executive.
Why it matters: The deal would add about $280 million in annual revenue. Approval and a clear closing date would move this large growth plan forward.
Supportive ifAddus reports that required approvals are complete and the deal has closed.
Worry ifAddus reports a failed approval, deal termination, or a closing delay with no new date.
Why it matters: Q2 revenue rose 8.0%, helped by higher care volumes and state rate increases. A similar Q3 result would show that growth continues.
Supportive ifIn the November 3 earnings report, Q3 revenue is at least 8.0% above the prior-year quarter.
Worry ifQ3 revenue growth is below 7.0%, or revenue falls year over year.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$87 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $245 loss on $10,000 · 2.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,682 loss on $10,000 · 26.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.